In people with T2DM, an i.v. glucose dose dependently suppressed glucagon even at elevated basal plasma glucose levels, while oral glucose caused an initial stimulation of glucagon that was not explained by the levels of incretin hormones [54,55]. The gene discussed is GCG; the disease is type 2 diabetes mellitus.